Conditioning Regimen of Bendamustine and Melphalan Followed by Transplant in Patients With Multiple Myeloma
Status:
Completed
Trial end date:
2018-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of Bendamustine (TREANDA™),
in combination with Melphalan in subjects with multiple myeloma who are undergoing an
Autologous Stem Cell Transplant.